Inventor

William J. McClellan

Inventor

Waukegan, IL, US

Overview

1986–2018

Patent span

Chemistry

Primary field (CPC C)

Patents· 32 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary

C07DHeterocyclic compounds36%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%

A61KPreparations for medical, dental or toiletry purposes18%

C07CAcyclic or carbocyclic compounds14%

C07BGeneral methods of organic chemistry3%

C04BLime, magnesia1%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%

G01NInvestigating or analysing materials by determining their chemical or physical properties1%

PatentTitleYear

10,131,657Bromodomain inhibitors2018 9,994,581Bromodomain inhibitors2018 9,957,263Bromodomain inhibitors2018 9,932,340Substituted indoles2018 9,321,764'Dihydro-pyrrolopyridinone inhibitors'2016 9,315,488'Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases'2016 9,296,741'Bromodomain inhibitors'2016 9,125,913'Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases'2015 9,072,748'BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases'2015 8,686,136'Apoptosis promoters'2014 8,614,318'Apoptosis promoters'2013 8,586,754'BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases'2013 8,563,735'Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases'2013 8,354,404'Apoptosis promoters'2013 8,173,811'Apoptosis promoters'2012 8,084,607'Apoptosis promoters'2011 7,973,161'Apoptosis promoters'2011 7,906,505'Apoptosis promoters'2011 7,767,684'Apoptosis promoters'2010 7,754,886'N-acylsulfonamide apoptosis promoters'2010 7,709,467'Apoptosis promoters'2010 7,642,260'Apoptosis promoters'2010 7,504,512'N-acylsulfonamide apoptosis promoters'2009 7,390,799'Apoptosis promoters'2008 6,720,338'N-acylsulfonamide apoptosis promoters'2004 6,504,031'Naphthamidine urokinase inhibitors'2003 6,284,796'Ukokinase inhibitors'2001 6,258,822'Urokinase inhibitors'2001 5,831,115'Inhibitors of squalene synthase and protein farnesyltransferase'1998 5,631,401'Inhibitors of protein farnesyltransferase and squalene synthase'1997 5,389,638'Tetrahydroisoquinolines as alpha-2 antagonists and biogenic amine uptake inhibitors'1995 4,618,683'Tetrahydro-6,7-dimethoxy-1H-benz[e]isoinodolines useful in the treatment of hypertension and as sedatives'1986

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1986–2013Patents assigned to ABBOTT LAB (18)· patent assignee history

1986–2018Based in Waukegan, IL, US· patent location history

2011–2013Patents assigned to BRUNCKO MILAN (6)· patent assignee history

2011–2013Patents assigned to DING HONG (6)· patent assignee history

2011–2013Patents assigned to PARK CHEOL-MIN (6)· patent assignee history

2013–2018Patents assigned to ABBVIE INC (13)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
ABBOTT LAB	18	1986–2013
ABBVIE INC	13	2013–2018
BRUNCKO MILAN	6	2011–2013
DING HONG	6	2011–2013
PARK CHEOL-MIN	6	2011–2013

Locations

Location	Patents	Span
Waukegan, Illinois, US	32	1986–2018